
No transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2021-02-12 | John A. Yarmuth | house | Purchase | $1,001 - $15,000 |
| 2020-11-05 | John A. Yarmuth | house | Purchase | $1,001 - $15,000 |
No financial data available for ACB.
Company may not file with SEC or CIK is unresolved.
SNDL sends pot stocks lower as market headwinds drive Q1 revenue miss
US Cannabis Market Report Analysis Report 2026-2034 Featuring Canopy Growth, Tilray Brands, Curaleaf, Aurora Cannabis, Jazz Pharma, GTI, Trulieve, Cresco Labs, Organigram Global, TerrAscend
Aurora Advances Global Medical Cannabis Portfolio with New Product Launches Across Key International Markets
Aurora Cannabis: Why I Like This Stock
AM Markets Need to Know: California on social media, cannabis stocks, and more
Cannabis selloff hits CRON, ACB, CGC, TLRY, OGI as reclassification seen limited
Why Trump didn't really 'legalize it'
Pot firms reverse gains on narrow scope of US rescheduling
Cannabis MSOs to see increased investment, lower taxes from reclassification
Finally. Marijuana Gets Reclassified, but Are Pot Stocks Still Too Risky?
Wall Street Lunch: Cannabis Stocks Fly High On DEA Rescheduling Move
Tilray Surges 10%: Rescheduling Momentum Builds as Traders Await Official Confirmation